Headache (peds)

Revision as of 23:13, 28 November 2019 by Rossdonaldson1 (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

This page is for pediatric patients. For adult patients, see: headache

Background

Headache Red Flags

Features

  • Sudden onset or accelerating pattern
  • Maximum intensity of pain at onset (i.e. "thunderclap")
  • Worse with valsalva
  • Worse in the morning or at night
  • No similar headache in past
  • Age >50 yr or <5 yr
  • Occipitonuchal headache
  • Visual disturbances
  • Exertional or postcoital
  • Family or personal history of SAH, cerebral aneurysm, or AVM
  • Focal neurologic signs
  • Diastolic BP >120
  • Papilledema
  • Jaw claudication

Clinical Context

Headache in setting of:

Clinical Features

Differential Diagnosis

Pediatric Headache

Evaluation

  • Neuroimaging if red-flag features
    • Routine imaging is not indicated in children with recurrent HA headaches and normal neuro exam
    • Consider imaging if abnormal neuro exam, altered mental status, concurrent seizure, severe HA or change in type

Diagnosis

  • Predictors of a surgical space-occupying lesion
    • Headache of <6 months duration
    • Sleep-related headache
    • Vomiting
      • Effortless vomiting but no GI complaints suggestive of elevated ICP
    • Confusion
    • Absence of family history of migraine
    • Abnormal findings on neuro exam
    • Torticollis
  • Strongly consider imaging in patients under 5 yrs who present with headaches

Management

Headache Type Treatment Comment
Migraine Ibuprofen, 10 milligrams/kg PO, or acetaminophen, 15 milligrams/kg PO/PR Ibuprofen superior to acetaminophen in one trial
 
Sumatriptan, 10 milligrams via nasal spray (20–39 kg) or 20 milligrams via nasal spray (>40 kg), or 0.06 milligram/kg SC Nasal or injectable preferred; no difference between oral sumatriptan and placebo
 
Rizatriptan, 5 milligrams PO Efficacy not statistically significant over placebo
 
Dihydroergotamine, 0.1 milligram/kg (ages 6–9), 0.15 milligram/kg (ages 9–12), 0.2 milligram/kg (ages 12–16) Contraindicated in complex migraine
Prochlorperazine, 0.15 milligram/kg IV Consider diphenhydramine 1 milligram/kg to prevent or treat dystonic reactions
Cluster 100% oxygen at 7 L/min via non-rebreather mask at onset of headache Most useful at onset of symptoms, less effective later in course of headache
Ergotamine, 0.1 milligram/dose (ages 6–9), 0.5 milligram/dose (ages 9–12), 0.75 milligram/dose (ages 12–16)
Sumatriptan Nasal spray or IM dosing as for migraine
Lidocaine, 1% solution in ipsilateral nostril Effective for mild to moderate pain, can instill via atomizer and syringe
Prednisone, 1–2 milligrams/kg for 10 d with subsequent 7-d taper Effective at terminating prolonged cluster headaches and preventing recurrence
Tension Ibuprofen, 10 milligrams/kg PO, or acetaminophen, 15 milligrams/kg PO/PR

Disposition

  • Discharge if primary headache provided pain is well controlled and child is well-appearing

See Also

External Links

References